Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
[
Type
]
Year
Filters:
Author
is
Al-Sawaf, Othman
[Clear All Filters]
Journal Article
Cramer P
,
von Tresckow J
,
Fink A-M
,
Robrecht S
,
Giza A
,
Tausch E
,
Müller L
,
Knauf W
,
Zingerle M
,
Al-Sawaf O
, et al.
Bendamustine, followed by obinutuzumab and idelalisib in chronic lymphocytic leukemia (CLL2-BCG): Final analysis of a multicenter, open-label phase-II-trial.
Am J Hematol. 2024.
PubMed
Google Scholar
Sönmez TTaha
,
Al-Sawaf O
,
Brandacher G
,
Kanzler I
,
Tuchscheerer N
,
Tohidnezhad M
,
Kanatas A
,
Knobe M
,
Fragoulis A
,
Tolba R
, et al.
A novel laser-Doppler flowmetry assisted murine model of acute hindlimb ischemia-reperfusion for free flap research.
PLoS One. 2013;8(6):e66498.
PubMed
Google Scholar
Al-Sawaf O
,
Fragoulis A
,
Rosen C
,
Keimes N
,
Liehn EAnamaria
,
Hölzle F
,
Kan YWai
,
Pufe T
,
Sönmez TTaha
,
Wruck CJan
.
Nrf2 augments skeletal muscle regeneration after ischemia-reperfusion injury.
J Pathol. 2014.
PubMed
Google Scholar
von Tresckow J
,
Cramer P
,
Robrecht S
,
Langerbeins P
,
Fink A-M
,
Al-Sawaf O
,
Fürstenau M
,
Illmer T
,
Klaproth H
,
Tausch E
, et al.
Sequential treatment with bendamustine, obinutuzumab (GA101) and Ibrutinib in chronic lymphocytic leukemia (CLL): final results of the CLL2-BIG trial.
Leukemia. 2022.
PubMed
Google Scholar
Al-Sawaf O
,
Ligtvoet R
,
Robrecht S
,
Stumpf J
,
Fink A-M
,
Tausch E
,
Schneider C
,
Boettcher S
,
Mikusko M
,
Ritgen M
, et al.
Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trial.
Nat Med. 2023.
PubMed
Google Scholar